Drugs / GODEX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06152991 | Sep 2023 → Jun 2026 overdue | NAFLD1 | Yoon Jun Kim | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Godex | “Orotic Acid Carnitine Complex Capsules (Godex®)” NCT06152991 ↗ |
| Known as | Orotic Acid Carnitine Complex Capsules | “Orotic Acid Carnitine Complex Capsules (Godex®)” NCT06152991 ↗ |
| Route | Oral | “Oral administration of 2 capsules of Godex® three times a day (tid) for 96 weeks” NCT06152991 ↗ |